{"id":"doi:10.1158/1078-0432.ccr-20-3863","kind":"article","title":"CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia","authors":["Yongxian Hu","Yali Zhou","Mingming Zhang","Wengang Ge","Yi Li","Li Yang","Guoqing Wei","Lu Han","Hao Wang","Shuhui Yu","Yi Chen","Yanbin Wang","Xiaohong He","Xingwang Zhang","Ming Jing Gao","Jingjing Yang","Xiuju Li","Jiangtao Ren","He Huang"],"author_count":19,"year":2021,"published":"2021-02-24","venue":"Clinical Cancer Research","cited_by":281,"doi":"10.1158/1078-0432.ccr-20-3863","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1158/1078-0432.ccr-20-3863","archive_url":"https://space-kitty.com/papers/doi:10.1158/1078-0432.ccr-20-3863","updated":null,"pmid":"33627493","pmcid":null,"openalex_id":"W3132062361","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"peer_reviewed":null,"categories":["CAR-T cell therapy research"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}